Alpsoy E - Search Results

1

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H. Sfikakis PP, et al. Among authors: alpsoy e. Rheumatology (Oxford). 2007 May;46(5):736-41. doi: 10.1093/rheumatology/kem034. Epub 2007 Apr 2. Rheumatology (Oxford). 2007. PMID: 17403712 Review. No abstract available.

2

Standard Patch Test Results and Clinical Relevance: A Cross-Sectional Study of 10-year Retrospective Experience.

Bilgic A, Bozca BC, Subası GY, Dicle Ö, Uzun S, Yılmaz E, Alpsoy E, Akman-Karakas A. Bilgic A, et al. Among authors: alpsoy e. Indian J Dermatol. 2022 May-Jun;67(3):258-264. doi: 10.4103/ijd.ijd_965_21. Indian J Dermatol. 2022. PMID: 36386088 Free PMC article.

3

Mucocutaneous manifestations of Behçet's disease: Pathogenesis and management from perspectives of vasculitis.

Kim D, Nakamura K, Kaneko F, Alpsoy E, Bang D. Kim D, et al. Among authors: alpsoy e. Front Med (Lausanne). 2022 Dec 2;9:987393. doi: 10.3389/fmed.2022.987393. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36530905 Free PMC article. Review.

4

Multiple familial pilomatrixomas.

Karpuzoglu T, Elpek GO, Alpsoy E, Gelen T, Aksoy NH, Karpuzoglu G. Karpuzoglu T, et al. Among authors: alpsoy e. J Eur Acad Dermatol Venereol. 2003 May;17(3):358-9. doi: 10.1046/j.1468-3083.2003.00792_8.x. J Eur Acad Dermatol Venereol. 2003. PMID: 12702091 No abstract available.

5

Epidermodysplasia verruciformis associated with neurofibromatosis type 1: coincidental association or model for understanding the underlying mechanism of the disease?

Alpsoy E, Ciftçioğlu MA, Keser I, De Villiers EM, Zouboulis CC. Alpsoy E, et al. Br J Dermatol. 2002 Mar;146(3):503-7. doi: 10.1046/j.1365-2133.2002.04551.x. Br J Dermatol. 2002. PMID: 11952554

6

Mucocutaneous lesions of Behcet's disease.

Alpsoy E, Zouboulis CC, Ehrlich GE. Alpsoy E, et al. Yonsei Med J. 2007 Aug 31;48(4):573-85. doi: 10.3349/ymj.2007.48.4.573. Yonsei Med J. 2007. PMID: 17722228 Free PMC article. Review.

7

Serum of patients with Behçet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro.

Alpsoy E, Kodelja V, Goerdt S, Orfanos CE, Zouboulis ChC. Alpsoy E, et al. Dermatology. 2003;206(3):225-32. doi: 10.1159/000068888. Dermatology. 2003. PMID: 12673080

8

Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach.

Alpsoy E, Leccese P, Emmi G, Ohno S. Alpsoy E, et al. Front Med (Lausanne). 2021 Apr 28;8:624795. doi: 10.3389/fmed.2021.624795. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33996847 Free PMC article. Review.

9

A randomized, controlled and blinded study of papulopustular lesions in Turkish Behçet's patients.

Alpsoy E, Aktekin M, Er H, Durusoy C, Yilmaz E. Alpsoy E, et al. Int J Dermatol. 1998 Nov;37(11):839-42. doi: 10.1046/j.1365-4362.1998.00401.x. Int J Dermatol. 1998. PMID: 9865870

10

The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study.

Alpsoy E, Er H, Durusoy C, Yilmaz E. Alpsoy E, et al. Arch Dermatol. 1999 May;135(5):529-32. doi: 10.1001/archderm.135.5.529. Arch Dermatol. 1999. PMID: 10328192 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page